Cellectis files to sell 44M ordinary shares for holders

This prospectus relates to the potential resale from time to time by AstraZeneca Holdings B.V. or its permitted transferees or assignees of up to 44M ordinary shares, including in the form of American Depositary Shares, of Cellectis (CLLS) S.A. Each ADS represents one ordinary share. The company is not offering or selling any ordinary shares or ADSs under this prospectus, and will not receive any proceeds from the sale or other disposition of the shares by the selling shareholder pursuant to this prospectus.